Effects of growth hormone (GH) and insulin-like growth factor-I therapy in patients with gene defects in the GH axis

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 3, 2006, Pages 229-236

  Riedl, Stefan ^a   Frisch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

GH antibodies; Growth hormone insensitivity syndrome; IGHD IA; Isolated growth hormone deficiency; Laron syndrome; rhIGF I therapy

Indexed keywords

CYCLOPHOSPHAMIDE; EPITOPE; GROWTH HORMONE; GROWTH HORMONE ANTIBODY; GROWTH HORMONE RECEPTOR; IMMUNOGLOBULIN G; RECOMBINANT SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; CASE REPORT; CHILD DEVELOPMENT; CHILD GROWTH; FEMALE; GENE DELETION; GENE MUTATION; GENETIC DISORDER; GROWTH ACCELERATION; GROWTH HORMONE DEFICIENCY; GROWTH INHIBITION; GROWTH RETARDATION; HORMONE RESISTANCE; HUMAN; HYPOGLYCEMIA; IMMUNOLOGICAL TOLERANCE; INJECTION SITE REACTION; LYMPHADENOPATHY; PUBERTY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 33645550128     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.3.229     Document Type: Article

References (36)

1. George DL, Phillips JA 3rd, Francke U, Seeburg PH. The genes for growth hormone and chorionic somatomammotropin are on the long arm of human chromosome 17 in region q21 to qter. Hum Genet 1981; 57: 138-141.
2. Phillips JA 3rd, Hjelle BL, Seeburg PH, Zachmann M. Molecular basis for familial isolated growth hormone deficiency. Proc Natl Acad Sci USA 1981; 78: 6372-6375.
3. Procter AM, Phillips JA 3rd, Cooper DN. The molecular genetics of growth hormone deficiency. Hum Genet 1998; 103: 255-272.
4. Wagner JK, Eble A, Hindmarsh PC, Mullis PE. Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 1998; 43: 105-110.
5. Binder G, Keller E, Mix M, Massa GG, Stokvis-Brantsma WH, Wit JM, Ranke MB. Isolated GH deficiency with dominant inheritance: New mutations, new insights. J Clin Endocrinol Metab 2001; 86: 3877-3881.
6. Illig R. Growth hormone antibodies in patients treated with different preparations of human growth hormone (hGH). J Clin Endocrinol Metab 1970; 31: 679-688.
7. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone: A new inborn error of metabolism? Isr J Med Sci 1966; 2: 152-155.
8. Eshet R, Laron Z, Pertzelan A, Dintzman M. Defect of growth hormone receptors in the liver of two patients with Laron-type dwarfism. Isr J Med Sci 1984; 20: 8-11.
9. Amselem S, Duquesnoy P, Attree O, Novelli G, Bousnina S, Postel-Vinay MC, Goossens M. Laron dwarfism and mutations of the growth hormone-receptor gene. N Engl J Med 1989; 321: 989-995.
10. Savage MO, Burren CP, Blair JC, Woods KA, Metherell L, Clark AJ, Camacho-Hubner C. Growth hormone insensitivity: Pathophysiology, diagnosis, clinical variation and future perspectives. Horm Res 2001; 55 (Suppl 2): 32-35.
11. Messina MF, De Luca F, Wasniewska M, Valenzise M, Lombardo F, Ghizzoni L. Final height in isolated GH deficiency type 1A: Effects of 5-year treatment with IGF-I. Eur J Endocrinol 2001; 144: 379-383.
12. Backeljauw PF, Underwood LE; GHIS Collaborative Study Group. Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: A clinical research center study. J Clin Endocrinol Metab 2001; 86: 1504-1510.
13. Laron Z. Laron syndrome (primary growth hormone resistance or insensitivity): The personal experience 1958-2003. J Clin Endocrinol Metab 2004; 89: 1031-1044.
14. Frisch H, Phillips JA 3rd. Growth hormone deficiency due to GH-N gene deletion in an Austrian family. Acta Endocrinol 1986; Suppl 279: 107-112.
15. Schwarz S, Berger P, Frisch H, Moncayo R, Phillips JA 3rd, Wick G. Growth hormone blocking antibodies in a patient with deletion of the GH-N gene. Clin Endocrinol 1987; 27: 213-224.
16. Cogan JD, Phillips JA 3rd, Sakati N, Frisch H, Schober E, Milner RDG. Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J Clin Endocrinol Metab 1993; 76: 1224-1228.
17. Prader A, Largo RH, Molinari L, Issler C. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989; 52: 1-125.
18. Zeisel HJ, Lutz A, Petrykowski W. Immunogenicity of mammalian cell-derived recombinant human growth hormone preparation during long-term treatment. Horm Res 1992; 37 (Suppl 2): 47-55.
19. Hauffa BP, Illig R, Torresani T, Stolecke H, Phillips JA 3rd. Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type A. Acta Endocrinol 1989; 121: 609-614.
20. Goodeve AC, Peake IR. The molecular basis of hemophilia A: genotype-phenotype relationships and inhibitor development. Semin Thromb Hemost 2003; 29: 23-30.
21. Key NS. Inhibitors in congenital coagulation disorders. Br J Haematol 2004; 127: 379-391.
22. Gilles JG, Desqueper B, Lenk H, Vermylen J, Saint-Remy JM. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitisation in patients with hemophilia A. J Clin Invest 1996; 97: 1382-1388.
23. Van Parijs L, Abbas AK. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off. Science 1998; 280: 243-248.
24. Woods KA, Dastot F, Preece MA, Clark AJ, Postel-Vinay MC, Chatelain PG, Ranke MB, Rosenfeld RG, Amselem S, Savage MO. Phenotype: Genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997; 82: 3529-3535.
25. Burren CP, Woods KA, Rose SJ, Tauber M, Price DA, Heinrich U, Gilli G, Razzaghy-Azar M, Al-Ashwal A, Crock PA, Rochiccioli P, Yordam N, Ranke MB, Chatelain PG, Preece MA, Rosenfeld RG, Savage MO. Clinical and endocrine characteristics in atypical and classical growth hormone insensitivity syndrome. Horm Res 2001; 55: 125-130.
26. Green H, Morikawa M, Nixon T. A dual effector theory of growth-hormone action. Differentiation 1985; 29: 195-198.
27. Van der Eerden BCJ, Karperien M, Wit JM. Systemic and local regulation of the growth plate. Endocr Rev 2003; 24: 782-801.
28. Gevers EF, van der Eerden BC, Karperien M, Raap AK, Robinson IC, Wit JM. Localization and regulation of the growth hormone receptor and growth hormone-binding protein in the rat growth plate. J Bone Miner Res 2002; 17: 1408-1419.
29. Ranke MB, Savage MO, Chatelain PG, Preece MA, Rosenfeld RG, Blum WF, Wilton P. Insulin-like growth factor I improves height in growth hormone insensitivity: Two years' results. Horm Res 1995; 44: 253-264.
30. Guevara-Aguirre J, Rosenbloom AL, Vasconez O, Martinez V, Gargosky SE, Allen L, Rosenfeld RG. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency. J Clin Endocrinol Metab 1997; 82: 629-633.
31. Laron Z, Klinger B. Effect of insulin-like growth factor-I treatment on serum androgens and testicular and penile size in males with Laron syndrome (primary growth hormone resistance). Eur J Endocrinol 1998; 138: 176-180.
32. Ruan W, Kleinberg DL. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 1999; 140: 5075-5081.
33. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O, Harada N. Aromatase in human bone tissue. J Bone Miner Res 1997; 12: 1416-1423.
34. Öz OK, Millsaps R, Welch R, Birch J, Zerwekh JE. Expression of aromatase in the human growth plate. J Mol Endocrinol 2001; 27: 249-253.
35. Savage MO, Camacho-Hubner C, Dunger DB. Therapeutic applications of the insulin-like growth factors. Growth Horm IGF Res 2004; 14: 301-308.
36. Gluckman PD, Gunn AJ, Wray A, Cutfield WS, Chatelain PG, Guilbaud O, Ambler GR, Wilton P, Albertsson-Wikland K. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr 1992; 121: 920-923.